TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)

Más betegség

• Patient suffering from a significant neurological disease (primary epilepsy, dementia, progressive degenerative neurological disorder, meningitis or encephalitis, hydrocephalus associated with increased intracranial pressure).

Egyéb

• Participant currently participating in a prospective clinical trial studying a different treatment than the one studied in this current prospective study.
• Patient currently breastfeeding.
• Patient who is pregnant, thinks she might be pregnant or is trying to become pregnant. Patient of childbearing potential must use a contraceptive method for the whole duration of their participation in the study.
• Patient with a known sensitivity to conductive hydrogels, such as gel used with electrocardiogram (ECG) or transcutaneous electrical nerve stimulation (TENS) electrodes.
• Patient with an active implanted medical device, a cranial defect (such as a missing bone that has not been replaced) or bullet fragments. Active electronic devices include, for example, deep brain stimulators, spinal cord stimulators, vagus nerve stimulators, pacemakers and defibrillators.
• Participant being deprived of liberty by a judicial or administrative decision, or who is under a measure of legal protection (e.g. guardianship or curatorship).

• Participant aged ≥ 18 years old.
• Participant with newly diagnosed GBM.
• Participant who completed radiochemotherapy after surgery or biopsy.
• Participant within first 2 cycles of maintenance TMZ.
• Participant for whom the physician has decided to initiate treatment with Optune® according to Instruction For Use or medical guidelines.